Lilly shares, Risinger observed, may be bound within that range near-term pending data from studies of two potential competitors to Mounjaro and Zepbound: Novo Nordisks Phase III candidate CagriSema and Amgen (NASDAQ: AMGN) s obesity candidate Maridebart Cafraglutide (MariTide), which is now in Phase II and wowed investors earlier this year
Hold the needle in place: When using a semaglutide pen, keep the needle under the skin for at least six seconds after Ozempic, or up to 10 seconds for Wegovy
Think of it like a personal prescription for energy and wellness
Clegg LE, Penland RC, Bachina S, Boulton DW, Thuresson M, Heerspink HJ, et al
Short takeaways B12 injections reliably correct deficiency and often restore energy quickly, but they are not a proven weight-loss therapy for people with normal B12 levels